Ardent Health Inc (ARDT) FinancialsARDTArdent Health Inc

Evaluating the bottom line, Ardent Health Inc maintains a gross margin of 55.77%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 3.47%, while the net margin is 2.14%. These profitability ratios, combined with a Return on Equity (ROE) of 6.01%, provide a clear picture of how effectively ARDT converts its operational activities into shareholder value.

In the context of the broader market, ARDT competes directly with industry leaders such as SGRY and BKD. With a market capitalization of $1.73B, it holds a significant position in the sector. When comparing efficiency, ARDT's gross margin of 55.77% stands against SGRY's 17.78% and BKD's 18.74%. Such benchmarking helps identify whether Ardent Health Inc is trading at a premium or discount relative to its financial performance.

The company has shown consistent revenue growth, with Q2 2026 revenue at $1.62 billion, slightly beating expectations despite a year-over-year decline of 1.8%. Gross margin remains strong at approximately 55.77% for Q2 2026, indicating solid profitability.